Originally published November 27 2005
Columbia researchers find herbal extract aids in fight against prostate cancer
by Mike Adams, the Health Ranger, NaturalNews Editor
Zyflamend®, an herbal extract, aids the body in suppressing the development of prostate cancer cells and also contributes to the self-destruction of existing prostate cells, according to new research from Columbia University.
The data, published in the October edition of Nutrition and Cancer, showed Zyflamend®, a patented formulation from New Chapter, has the ability, in vitro, to reduce prostate cancer cell proliferation by as much as 78 percent and to induce cancer cell death or apoptosis.
The research confirms Zyflamend® has COX-1 and COX-2 anti-inflammatory effects, although its anti-cancer affects against prostate cancer were independent of COX-2 inhibition, supporting the postulation that some prostate cancer cells are not affected by COX-2 inflammation.
"These results were particularly surprising and show great promise in the fight against prostate cancer," said researcher Dr. Debra L. Bemis of the Columbia University Department of Urology.
Based on this research, Zyflamend® shows value in early therapy for prostate cancer patients.
COX inhibitors have also shown value for prostate cancer patients, but data from recent trials of selective COX-2 inhibitors such as sulindac (Clinoril®) and celecoxib (Celebrex®), suggest that use of these drugs might have adverse cardiovascular effects.
The more widely utilized general COX inhibitor, aspirin, is not associated with these negative side effects and, instead, has well-established beneficial effects for individuals with cardiovascular disease.
Dr. Bemis added: "Zyflamend® is derived from natural herbal sources and is readily available in health food and nutritional supplement stores.
On the strength of this laboratory research, Columbia University's Department of Urology has commenced a Phase 1 human clinical trial testing Zyflamend's ability to prevent prostate cancer in patients with prostatic intraepithelial neoplasia (PIN).
Without intervention, men diagnosed with PIN have a 50 to 70 percent likelihood of developing prostate cancer.
"We are encouraged that this study provides additional scientific evidence that specific herbal preparations can produce a positive impact on prostate health," said Mark Blumenthal, founder and executive director of the non-profit American Botanical Council.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml